Skip to content

Comparison of Holter vs S-Patch for Arrhythmia Detection in Older Falls Patient

Comparison of Holter vs S-Patch for Arrhythmia Detection in Older Falls Patient

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06977789
Enrollment
73
Registered
2025-05-18
Start date
2020-07-03
Completion date
2023-12-25
Last updated
2025-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradyarrhythmia, Arrythmia

Brief summary

The aim of this study is to compare Holter versus S patch in a group of elderly patients who are referred to the Geriatrics service in Changi General Hospital for falls from Accident and Emergency department, clinic and wards. The investigator hope to assess the feasibility, adherence and patient acceptability as an alternative to Holter monitoring. The investigator also hope to learn if S-Patch EX monitoring system can be as effective or equivalent to Holter in the monitoring of arrhythmias and the possibility of deploying it for longer term monitoring of arrhythmias. Participants who consented to be in this study will be offered S patch and Holter consecutively. Holter will be worn for 24 hours and S patch will be worn for 72 hours. The order which Holter or S patch will be worn first will be determined via randomisation.

Interventions

DEVICES Patch3-Cardio/S-Patch Ex

S Patch3-Cardio/S-Patch Ex for 72 hours

DEVICEHolter

Holter for 24 hours

Sponsors

Samsung SDS Asia Pacific Pte Ltd
CollaboratorUNKNOWN
Changi General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 60 to 120 year old inclusive 2. Refer for Holter testing as part of clinical care 3. Participants with symptoms suspected to be due to bradyarrhythmia. This could include, but not limited to unwitnessed fall, syncope, near syncope.

Exclusion criteria

1. Participants who are already known to have significant bradyarrhythmia who would benefit from a permanent pacemaker. 2. Patients unable to tolerate Holter monitoring.

Design outcomes

Primary

MeasureTime frameDescription
Participant's ComplianceFrom date of randomization until the day participant completed both device monitoring, assessed up to 4 days.An events diary and questionnaire to evaluate their preference between Holter and the S-Patch recorder. The hours of recording from both devices will also be captured in both devices report.

Secondary

MeasureTime frameDescription
Device sensitivity and specificity72 hours for S Patch3-Cardio/S-Patch Ex and 24hours for HolterAssess sensitivity and specificity of S Patch3-Cardio/S-Patch Ex compared to Holter to diagnose the bradyarrhythmia/arrhythmia. The sensitivity and specificity will be analyzed from the device report. Outcome comparison between the two treatment arms using McNemars test.
Durability of the device72 hours for S Patch3-Cardio/S-Patch Ex and 24hours for HolterDurability of the device in longer term monitoring and in real world situation. The hours of monitoring from S Patch3-Cardio/S-Patch Ex is compare with hours of monitoring from Holter to see if 72 hours of monitoring will have a better outcome compare to only 24hrs of recording. The duration of recording are taken from the device monitoring reports.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026